Europe · Markets & Finance · BFM Bourse

Jefferies impressionné par les résultats de Genmab dans une étude de phase 3

Published by BFM Bourse · France 11 h ago

(Zonebourse.com) - Genmab signe la plus forte hausse du Stoxx Europe 600 peu après l'ouverture ( 7,87%, à 2 564 couronnes danoises) ...

Read the full article on BFM Bourse Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingsat.com)

Also worth reading

Bids for 2036 Olympic Games due by end of the month

Buyers now shell out £17,500 to move home as stamp duty drives huge rise in bills in last decade

Financial Times

California’s oligarch tax would change America

Euro: Balancing pressures as Fed path repriced – OCBC

Reuters Markets

Mapping the Market: Swiss franc could extend sharp rally vs euro on French budget woes

Proactive Investors

Prediction markets give Nasdaq-100 a 68% chance of finishing 2026 above 31,000